211 related articles for article (PubMed ID: 34580281)
1. USP7 facilitates SMAD3 autoregulation to repress cancer progression in p53-deficient lung cancer.
Huang YT; Cheng AC; Tang HC; Huang GC; Cai L; Lin TH; Wu KJ; Tseng PH; Wang GG; Chen WY
Cell Death Dis; 2021 Sep; 12(10):880. PubMed ID: 34580281
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of USP7 upregulates USP22 and activates its downstream cancer-related signaling pathways in human cancer cells.
Zhang K; Sun T; Li W; Guo Y; Li A; Hsieh M; Wang J; Wu J; Arvanitis L; Raz DJ
Cell Commun Signal; 2023 Nov; 21(1):319. PubMed ID: 37946202
[TBL] [Abstract][Full Text] [Related]
3. A feedforward circuit shaped by ECT2 and USP7 contributes to breast carcinogenesis.
Zhang Q; Cao C; Gong W; Bao K; Wang Q; Wang Y; Bi L; Ma S; Zhao J; Liu L; Tian S; Zhang K; Yang J; Yao Z; Song N; Shi L
Theranostics; 2020; 10(23):10769-10790. PubMed ID: 32929379
[No Abstract] [Full Text] [Related]
4. Inhibition of USP7 induces p53-independent tumor growth suppression in triple-negative breast cancers by destabilizing FOXM1.
Yi J; Li H; Chu B; Kon N; Hu X; Hu J; Xiong Y; Kaniskan HU; Jin J; Gu W
Cell Death Differ; 2023 Jul; 30(7):1799-1810. PubMed ID: 37291217
[TBL] [Abstract][Full Text] [Related]
5. USP7 small-molecule inhibitors interfere with ubiquitin binding.
Kategaya L; Di Lello P; Rougé L; Pastor R; Clark KR; Drummond J; Kleinheinz T; Lin E; Upton JP; Prakash S; Heideker J; McCleland M; Ritorto MS; Alessi DR; Trost M; Bainbridge TW; Kwok MCM; Ma TP; Stiffler Z; Brasher B; Tang Y; Jaishankar P; Hearn BR; Renslo AR; Arkin MR; Cohen F; Yu K; Peale F; Gnad F; Chang MT; Klijn C; Blackwood E; Martin SE; Forrest WF; Ernst JA; Ndubaku C; Wang X; Beresini MH; Tsui V; Schwerdtfeger C; Blake RA; Murray J; Maurer T; Wertz IE
Nature; 2017 Oct; 550(7677):534-538. PubMed ID: 29045385
[TBL] [Abstract][Full Text] [Related]
6. FAM188B enhances cell survival via interaction with USP7.
Choi ES; Lee H; Sung JY; Lee CH; Jang H; Kim KT; Kim YN; Kim HP; Goh SH
Cell Death Dis; 2018 May; 9(6):633. PubMed ID: 29795372
[TBL] [Abstract][Full Text] [Related]
7. TSPY1 suppresses USP7-mediated p53 function and promotes spermatogonial proliferation.
Shen Y; Tu W; Liu Y; Yang X; Dong Q; Yang B; Xu J; Yan Y; Pei X; Liu M; Xu W; Yang Y
Cell Death Dis; 2018 May; 9(5):542. PubMed ID: 29748603
[TBL] [Abstract][Full Text] [Related]
8. USP7 promotes cell proliferation through the stabilization of Ki-67 protein in non-small cell lung cancer cells.
Zhang C; Lu J; Zhang QW; Zhao W; Guo JH; Liu SL; Wu YL; Jiang B; Gao FH
Int J Biochem Cell Biol; 2016 Oct; 79():209-221. PubMed ID: 27590858
[TBL] [Abstract][Full Text] [Related]
9. MLF2 Negatively Regulates P53 and Promotes Colorectal Carcinogenesis.
Fang D; Hu H; Zhao K; Xu A; Yu C; Zhu Y; Yu N; Yao B; Tang S; Wu X; Mei Y
Adv Sci (Weinh); 2023 Sep; 10(26):e2303336. PubMed ID: 37438558
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, biological evaluation and structure-activity relationship study of quinazolin-4(3H)-one derivatives as novel USP7 inhibitors.
Li P; Liu Y; Yang H; Liu HM
Eur J Med Chem; 2021 Apr; 216():113291. PubMed ID: 33684824
[TBL] [Abstract][Full Text] [Related]
11. Recent advances on the intervention sites targeting USP7-MDM2-p53 in cancer therapy.
Harakandi C; Nininahazwe L; Xu H; Liu B; He C; Zheng YC; Zhang H
Bioorg Chem; 2021 Nov; 116():105273. PubMed ID: 34474304
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a Potent and Selective Degrader for USP7.
Pei Y; Fu J; Shi Y; Zhang M; Luo G; Luo X; Song N; Mi T; Yang Y; Li J; Zhou Y; Zhou B
Angew Chem Int Ed Engl; 2022 Aug; 61(33):e202204395. PubMed ID: 35691827
[TBL] [Abstract][Full Text] [Related]
13. WDR79 promotes the proliferation of non-small cell lung cancer cells via USP7-mediated regulation of the Mdm2-p53 pathway.
Sun Y; Cao L; Sheng X; Chen J; Zhou Y; Yang C; Deng T; Ma H; Feng P; Liu J; Tan W; Ye M
Cell Death Dis; 2017 Apr; 8(4):e2743. PubMed ID: 28406480
[TBL] [Abstract][Full Text] [Related]
14. STIP is a critical nuclear scaffolding protein linking USP7 to p53-Mdm2 pathway regulation.
Ye M; Tang Y; Tang S; Liu J; Wu K; Yao S; Sun Y; Zhou L; Deng T; Chen Y; Huang C; Tan W
Oncotarget; 2015 Oct; 6(33):34718-31. PubMed ID: 26460617
[TBL] [Abstract][Full Text] [Related]
15. USP7 inhibition alters homologous recombination repair and targets CLL cells independently of ATM/p53 functional status.
Agathanggelou A; Smith E; Davies NJ; Kwok M; Zlatanou A; Oldreive CE; Mao J; Da Costa D; Yadollahi S; Perry T; Kearns P; Skowronska A; Yates E; Parry H; Hillmen P; Reverdy C; Delansorne R; Paneesha S; Pratt G; Moss P; Taylor AMR; Stewart GS; Stankovic T
Blood; 2017 Jul; 130(2):156-166. PubMed ID: 28495793
[TBL] [Abstract][Full Text] [Related]
16. USP7 targeting modulates anti-tumor immune response by reprogramming Tumor-associated Macrophages in Lung Cancer.
Dai X; Lu L; Deng S; Meng J; Wan C; Huang J; Sun Y; Hu Y; Wu B; Wu G; Lovell JF; Jin H; Yang K
Theranostics; 2020; 10(20):9332-9347. PubMed ID: 32802195
[No Abstract] [Full Text] [Related]
17. USP7 Inhibition Suppresses Neuroblastoma Growth via Induction of p53-Mediated Apoptosis and EZH2 and N-Myc Downregulation.
Le Clorennec C; Lee K; Huo Y; Zage PE
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762082
[TBL] [Abstract][Full Text] [Related]
18. USP7 overexpression predicts a poor prognosis in lung squamous cell carcinoma and large cell carcinoma.
Zhao GY; Lin ZW; Lu CL; Gu J; Yuan YF; Xu FK; Liu RH; Ge D; Ding JY
Tumour Biol; 2015 Mar; 36(3):1721-9. PubMed ID: 25519684
[TBL] [Abstract][Full Text] [Related]
19. USP7 inhibitor P22077 inhibits neuroblastoma growth via inducing p53-mediated apoptosis.
Fan YH; Cheng J; Vasudevan SA; Dou J; Zhang H; Patel RH; Ma IT; Rojas Y; Zhao Y; Yu Y; Zhang H; Shohet JM; Nuchtern JG; Kim ES; Yang J
Cell Death Dis; 2013 Oct; 4(10):e867. PubMed ID: 24136231
[TBL] [Abstract][Full Text] [Related]
20. Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells.
Colland F; Formstecher E; Jacq X; Reverdy C; Planquette C; Conrath S; Trouplin V; Bianchi J; Aushev VN; Camonis J; Calabrese A; Borg-Capra C; Sippl W; Collura V; Boissy G; Rain JC; Guedat P; Delansorne R; Daviet L
Mol Cancer Ther; 2009 Aug; 8(8):2286-95. PubMed ID: 19671755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
